Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interleukin-11 for Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma
NCT03720340Phase 3Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Oct 2018
- Primary completion
- Aug 2021
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of oprelvekin in oral mucositis (OM), sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
oprelvekin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT03720340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03720340.